MGC (ASX:MXC) will conduct a head-to-head clinical study on severe intractable epilepsy in collaboration with Cannabis Access Clinics and Epilepsy Action Australia, a direct comparison assessing the efficacy of low-THC to 100 per cent CBD products when treating severe intractable epilepsy.
Read more :
Vaping laws changed in Australia on 1st October 2021, making nicotine-containing vape liquid a Schedule 4 prescription-only medicine.
Applied Cannabis Research welcomes PM Scott Morrison’s announcement of a Royal Commission into suicide among Australia’s veterans and serving Defence personnel. We
Aruma Labs teams up with Applied Cannabis Research for endometriosis observational study Applied Cannabis Research is pleased to announce Aruma Labs (Aruma)
© 2022 All rights reserved, Applied Cannabis Research
